Literature DB >> 10073594

Osteopontin expression in fetal and mature human kidney.

K L Hudkins1, C M Giachelli, Y Cui, W G Couser, R J Johnson, C E Alpers.   

Abstract

Osteopontin is a secreted phosphoprotein that is expressed by normal kidney, and has been associated with a number of functions including cell adhesion, migration, signaling, and biomineralization. Although there is a vast literature detailing osteopontin localization in various rodent models of both development and disease, this article presents the first comprehensive description of osteopontin localization in human kidney. In this study, immunohistochemistry, immunoelectron microscopy, in situ hybridization, and Northern blotting are used to analyze osteopontin protein and mRNA expression in human fetal and normal mature renal tissue. Osteopontin is expressed in the human embryonic renal tubular epithelium beginning on approximately day 75 to 80 of gestation. In the fetal kidney, osteopontin can also be seen occasionally expressed in the ureteric buds and in some interstitial cells. As localized at the protein and mRNA level, the tubular expression of osteopontin increases with increasing gestational age and persists into adulthood. In the normal adult kidney, osteopontin is localized primarily to the distal nephron and is strongly expressed by the thick ascending limb of the loops of Henle. Osteopontin expression can also be observed in some collecting duct epithelium. In cases that exhibit foci of interstitial fibrosis and an associated influx of interstitial macrophages, osteopontin expression is significantly upregulated in all tubular segments, including proximal tubules.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10073594     DOI: 10.1681/ASN.V103444

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  24 in total

1.  Bone morphogenetic protein 4: potential regulator of shear stress-induced graft neointimal atrophy.

Authors:  Patrick C H Hsieh; Richard D Kenagy; Eileen R Mulvihill; Joseph P Jeanette; Xi Wang; Cindy M C Chang; Zizhen Yao; Walter L Ruzzo; Suzanne Justice; Kelly L Hudkins; Charles E Alpers; Scott Berceli; Alexander W Clowes
Journal:  J Vasc Surg       Date:  2006-01       Impact factor: 4.268

2.  Urinary Osteopontin Predicts Incident Chronic Kidney Disease, while Plasma Osteopontin Predicts Cardiovascular Death in Elderly Men.

Authors:  Tobias Feldreich; Axel C Carlsson; Johanna Helmersson-Karlqvist; Ulf Risérus; Anders Larsson; Lars Lind; Johan Ärnlöv
Journal:  Cardiorenal Med       Date:  2017-05-25       Impact factor: 2.041

3.  The selective NADPH oxidase inhibitor apocynin has potential prophylactic effects on melamine-related nephrolithiasis in vitro and in vivo.

Authors:  Xiaoran Li; Jianzhong Lu; Panfeng Shang; Junsheng Bao; Zhongjin Yue
Journal:  Mol Cell Biochem       Date:  2014-10-16       Impact factor: 3.396

4.  Osteopontin protects against high phosphate-induced nephrocalcinosis and vascular calcification.

Authors:  Neil J Paloian; Elizabeth M Leaf; Cecilia M Giachelli
Journal:  Kidney Int       Date:  2016-03-09       Impact factor: 10.612

5.  Peculiarities of the extracellular matrix in the interstitium of the renal stem/progenitor cell niche.

Authors:  Will W Minuth; Lucia Denk; Christian Miess; Anne Glashauser
Journal:  Histochem Cell Biol       Date:  2011-08-06       Impact factor: 4.304

6.  Up-regulation of the tumour-associated marker CD44V6 in experimental kidney disease.

Authors:  K Takazoe; R Foti; G H Tesch; L A Hurst; H Y Lan; R C Atkins; D J Nikolic-Paterson
Journal:  Clin Exp Immunol       Date:  2000-09       Impact factor: 4.330

7.  Longitudinal patterns of urine biomarkers in infants across gestational ages.

Authors:  Marissa J DeFreitas; Wacharee Seeherunvong; Chryso P Katsoufis; Satish RamachandraRao; Shahnaz Duara; Salih Yasin; Gaston Zilleruelo; Maria M Rodriguez; Carolyn L Abitbol
Journal:  Pediatr Nephrol       Date:  2016-02-09       Impact factor: 3.714

Review 8.  The role of acidic phosphoproteins in biomineralization.

Authors:  Keith Alvares
Journal:  Connect Tissue Res       Date:  2014 Jan-Feb       Impact factor: 3.417

Review 9.  The role of osteopontin in kidney diseases.

Authors:  Beata Kaleta
Journal:  Inflamm Res       Date:  2018-11-19       Impact factor: 4.575

10.  Plasma biomarkers improve prediction of diabetic kidney disease in adults with type 1 diabetes over a 12-year follow-up: CACTI study.

Authors:  Petter Bjornstad; Laura Pyle; David Z I Cherney; Richard J Johnson; Rachel Sippl; Randy Wong; Marian Rewers; Janet K Snell-Bergeon
Journal:  Nephrol Dial Transplant       Date:  2018-07-01       Impact factor: 5.992

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.